Heroin addiction treatment
Executive Summary
House Commerce Committee passes Committee Chairman Bliley's (R-Va.) "Drug Addiction Treatment Act" (HR 2634) that would allow Schedule IV and V addiction treatment medications to be provided in physician offices, eliminating the perceived stigma of the clinic setting. Reckitt & Coleman's Suboxone (buprenorphine/naloxone) for heroin addiction, currently under review at FDA, would benefit from the bill